Mounier-Vehier C, Amah G, Duquenoy S, Fontaine P, Phan T M
Service de médecine interne et HTA, hôpital cardiologique, CHRU, 59037 Lille.
Arch Mal Coeur Vaiss. 2003 Jul-Aug;96(7-8):792-5.
According to ANAES guidelines (2000) adapted from the international guidelines, kidney function should be regularly monitored in hypertensive patients in order to detect vascular nephropathy at an early stage and prevent kidney failure which is a major cardiovascular factor. The PHENOMEN survey was conducted between January and July 2001 on a representative sample of 16,358 patients suffering from hypertension being followed by a General Practitioner (GP). The population included patients from all 22 administrative regions in France.
To determine the prevalence of renal involvement in patients with hypertension (both treated and untreated); to compare the GP's subjective evaluation of the extent of renal involvement with a more objective assessment made according to ANAES guidelines.
Kidney function was evaluated by measuring plasma creatinine levels to derive a value for the creatinine clearance rate (CCR) using the Cockeroft-Gault formula.
Out of the 16,358 patients included, plasma creatinine levels could be measured in 11,586 (76%) [53% men; 47% women, mean age = 63 +/- 12 years]: mean plasma creatinine = 90 +/- 49 mumol/l, i.e. a mean CCR of 83 +/- 32 ml/min. For 8,650 of the patients (75%), kidney function had been monitored in the preceding twelve months. The physicians defined their patient's kidney function as normal in 10,080 (87%) of cases whereas in reality, 4,411 of 8,650 (51%) were suffering from some degree of renal insufficiency (RI): in 2,422 (28%), RI was mild (> or = 60 CCR < 80 ml/min): in 1,903 (22%) RI was moderate (> or = 30 CCR < 60 ml/min). A minority of patients (44 i.e. 1%) showed severe RI (CCR < 30 ml/min).
Most GPs apply ANAES guidelines and order plasma creatinine assays. However, there is a discrepancy between how the physician "perceives" the seriousness of the renal insufficiency and a more objective measure based on the CCR figure. It would seem that the CCR derivative is insufficiently exploited despite the widespread availability of converters. Thus, the PHENOMEN survey has revealed that the extent of renal involvement in patients with hypertension still tends to be underestimated by GPs despite the major implications of this complication in terms of therapeutic strategy and global cardiovascular risk.
根据改编自国际指南的法国麻醉与重症监护学会(ANAES)指南(2000年),高血压患者应定期监测肾功能,以便早期发现血管性肾病并预防肾衰竭,而肾衰竭是一个主要的心血管危险因素。“PHENOMEN调查”于2001年1月至7月进行,样本为16358名由全科医生(GP)随访的高血压患者,具有代表性。该人群包括来自法国所有22个行政区的患者。
确定高血压患者(包括接受治疗和未接受治疗的患者)肾脏受累的患病率;比较全科医生对肾脏受累程度的主观评估与根据ANAES指南进行的更客观的评估。
通过测量血浆肌酐水平来评估肾功能,使用Cockcroft - Gault公式得出肌酐清除率(CCR)的值。
在纳入的16358名患者中,11586名(76%)[男性53%;女性47%,平均年龄 = 63 ± 12岁]的血浆肌酐水平可测:平均血浆肌酐 = 90 ± 49 μmol/l,即平均CCR为83 ± 32 ml/min。在8650名患者(75%)中,前十二个月内对肾功能进行了监测。医生将10080例(87%)患者的肾功能定义为正常,而实际上,8650名患者中有4411名(51%)存在某种程度的肾功能不全(RI):2422名(28%)为轻度RI(≥ 60 CCR < 80 ml/min);1903名(22%)为中度RI(≥ 30 CCR < 60 ml/min)。少数患者(44名,即1%)表现为重度RI(CCR < 30 ml/min)。
大多数全科医生应用ANAES指南并安排血浆肌酐检测。然而,医生对肾功能不全严重程度的“感知”与基于CCR数值的更客观测量之间存在差异。尽管有广泛可用的换算工具,但CCR衍生指标似乎未得到充分利用。因此,“PHENOMEN调查”显示,尽管这种并发症对治疗策略和整体心血管风险有重大影响,但全科医生对高血压患者肾脏受累程度的估计仍往往偏低。